Celldex Therapeutics Inc (NASDAQ:CLDX)
| 36.00 Delayed Data As of Mar 31 |  +0.42 / +1.18%Today’s Change | 19.85 Today|||52-Week Range 48.40 | -19.23% Year-to-Date |
Latest CLDX News | Press Releases
No recent news for Celldex Therapeutics Inc.
Today’s Trading
| Previous close | 35.58 |
| Today’s open | 35.44 |
| Day’s range | 35.44 - 36.12 |
| Volume | 19,962 |
| Average volume (3 months) | 515,193 |
| Market cap | $16.1M |
Data as of 4:00pm ET, 03/31/2023
Growth & Valuation
| Earnings growth (last year) | -45.65% |
| Earnings growth (this year) | -5.00% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -49.32% |
| P/E ratio | NM |
| Price/Sales | 886.64 |
| Price/Book | 0.05 |
Competitors
Data as of 4:00pm ET, 03/31/2023
Financials
| Next reporting date | May 10, 2023 |
| EPS forecast (this quarter) | -$0.62 |
| Annual revenue (last year) | $2.4M |
| Annual profit (last year) | -$112.3M |
| Net profit margin | -4,765.59% |
Profile
Sector Health Services |
Industry Medical/Nursing Services |
No executives to display |
Corporate headquarters Hampton, New Jersey |
Forecasts
